Articles

Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial

Hori M, Zhu J, Liang Y, et al.

Journal: 

Eur Heart J

First published: June 25, 2022  DOI: 10.1093/eurheartj/ehac309